The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
Feature|Videos|August 31, 2023
Dr. Peter Grinspoon on Medical Cannabis Truth and Policies
Author(s)Madeline Colli
In this Deep Dive interview, Dr. Peter Grinspoon, a keynote speaker at the Cannabis Science Conference Fall, shares his views on cannabis policies, insights from his latest book, and what he hopes to see in the future of medical cannabis.
Advertisement
Listen as Dr. Peter Grinspoon, a primary care doctor at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and a 25-year cannabis specialist, shares his thoughts and experience on all things related to medical cannabis.
Advertisement
Related to this article
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
This month’s webinar explored published research studies on cannabis and its effect on opioids, substance use reduction, alcohol use, and autism symptoms.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
Zacariah Hildenbrand, PhD and Adam Jacques delve into how genetics affect terpenes in the cultivar of a cannabis plant.
Zacariah Hildenbrand, PhD and Adam Jacques discuss how cannabis genetics affect cannabinoids.
A recent study found that medical cannabis may play a role in decreasing opioid use.
Advertisement
Advertisement